iDtheinvestordatabase
Home / Directory / Cure Ventures
Active: new fund Dec 2025 Verified 4 Nov 2026

Cure Ventures

Venture firm building and backing therapeutics companies with entrepreneurs, with a focus on drug discovery and evidence-based development.

Type
VC firm
Location
Boston, Massachusetts, United States
Stages
Pre-seed, Seed
Backs
Biotech and pharma
Sectors
Biotech, Healthtech and life sciences
Fund size / AUM
$350.5M Cure Ventures Fund I (Form D offering, 2021)
Latest fund or filing
18 Dec 2025
Portfolio mix
Biotech and pharma 92%; Medtech and digital health 8% (n=12)

Fund filings (SEC Form D)

Latest fund on file
Cure Ventures Fund II
Filed
18 Dec 2025 (new notice)
Fund size
Not disclosed on the filing
Fund vehicles filed in the last 12 months
1 (includes feeder and parallel vehicles)

See this fund's filings on SEC EDGAR

Contacts on file

For Cure Ventures, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

XenImmuneTasca Therapeutics

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 23 lists